Hybio Pharmaceutical's controlling shareholder adjusts share pledges

Zeng Shaogui, the controlling shareholder and actual controller of Hybio Pharmaceutical, has reported new share pledge and release transactions. A total of 19,000,000 shares were pledged across two transactions, each for 13,000,000 shares and 6,000,000 shares respectively. These pledges represent 1.47% and 0.68% of the company's total share capital, securing financing from Shenzhen High-tech Investment Guarantee Co., Ltd. The pledges are set to expire on December 16, 2025.

Concurrently, Zeng Shaogui also released 19,000,000 pledged shares, representing 2.15% of the company's total share capital. This release transaction, with Shenzhen High-tech Investment Guarantee Co., Ltd. as the original pledgee, took place between July 27, 2025, and December 17, 2025.

Following these adjustments, Zeng Shaogui's total pledged shares remain at 47,190,000, representing 47.89% of his holdings and 5.34% of the company's total share capital. Of these pledged shares, 43,468,054 are restricted or frozen, accounting for 92.11% of his pledged shares. His unpledged shares amount to 30,432,172, with 59.27% of these being restricted or frozen.